- Investing Ideas
- Global Pharmaceuticals & Biotech Leverage Leaders
Global Pharmaceuticals & Biotech Leverage Leaders
Results
218
218 companies
Relay Therapeutics
Market Cap: US$4.0b
Operates as a clinical-stage precision medicines company.
RLAY
US$18.56
7D
16.9%
1Y
462.4%
West Pharmaceutical Services
Market Cap: US$24.8b
Designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
WST
US$350.85
7D
7.0%
1Y
60.3%
BioMarin Pharmaceutical
Market Cap: US$11.4b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$59.00
7D
7.9%
1Y
6.9%
Pharvaris
Market Cap: US$2.4b
A late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases.
PHVS
US$34.01
7D
3.7%
1Y
100.1%
Veracyte
Market Cap: US$4.8b
Operates as a diagnostics company in the United States and internationally.
VCYT
US$60.49
7D
12.8%
1Y
120.9%
China Resources Jiangzhong PharmaceuticalLtd
Market Cap: CN¥14.1b
Engages in the manufacture of pharmaceutical products in China.
600750
CN¥22.42
7D
-7.8%
1Y
2.3%
Simcere Pharmaceutical Group
Market Cap: HK$23.8b
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.
2096
HK$9.27
7D
-3.2%
1Y
-15.7%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥42.1b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥93.47
7D
10.0%
1Y
0.4%
China Medical System Holdings
Market Cap: HK$24.0b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$9.93
7D
-4.5%
1Y
-17.3%
Voronoi
Market Cap: ₩3.1t
Researches, develops, and discovers small molecule kinase inhibitors in South Korea.
A310210
₩170,800.00
7D
-12.4%
1Y
47.8%
Joinn Laboratories(China)Co.Ltd
Market Cap: CN¥24.9b
Provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally.
603127
CN¥37.08
7D
4.0%
1Y
93.9%
Pfizer
Market Cap: ₹204.1b
Engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally.
PFIZER
₹4,460.70
7D
-1.6%
1Y
-21.7%
Yili Chuanning BiotechnologyLtd
Market Cap: CN¥17.6b
Engages in the research, development, and industrialization of bio-fermentation technology and synthetic biology products in China and internationally.
301301
CN¥7.90
7D
-6.2%
1Y
-34.0%
Regencell Bioscience Holdings
Market Cap: US$3.2b
Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.
RGC
US$6.48
7D
-46.0%
1Y
-62.8%
Caplin Point Laboratories
Market Cap: ₹190.6b
Engages in the development, production, marketing, and export of generic formulations and branded products in India.
524742
₹2,507.25
7D
0.04%
1Y
20.3%
Natera
Market Cap: US$37.5b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$261.91
7D
13.2%
1Y
55.9%
AbCellera Biologics
Market Cap: US$2.3b
Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.
ABCL
US$7.38
7D
33.5%
1Y
104.4%
Chengdu Kanghong Pharmaceutical Group
Market Cap: CN¥18.0b
Engages in the research, development, manufacture, and sale of pharmaceuticals and medical devices in China.
002773
CN¥19.51
7D
-1.5%
1Y
-31.9%
Gan & Lee Pharmaceuticals
Market Cap: CN¥32.0b
A biopharmaceutical company, engages in the development, production, and commercialization of insulin analogs and medical devices in China.
603087
CN¥53.77
7D
-5.2%
1Y
0.3%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹399.6b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,358.85
7D
1.1%
1Y
-31.8%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥13.8b
Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.
300573
CN¥38.62
7D
6.0%
1Y
9.5%
10x Genomics
Market Cap: US$4.7b
Develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific.
TXG
US$36.75
7D
5.7%
1Y
213.3%
Edgewise Therapeutics
Market Cap: US$4.5b
A biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders.
EWTX
US$41.46
7D
12.6%
1Y
214.8%
Aurinia Pharmaceuticals
Market Cap: US$2.2b
A biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan.
AUPH
US$17.23
7D
4.7%
1Y
99.4%
Immunovant
Market Cap: US$8.0b
A clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases.
IMVT
US$38.85
7D
9.9%
1Y
141.3%
Acutaas Chemicals
Market Cap: ₹270.2b
Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.
ACUTAAS
₹3,300.00
7D
1.7%
1Y
189.1%
Kymera Therapeutics
Market Cap: US$8.9b
A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.
KYMR
US$108.12
7D
19.6%
1Y
145.1%
Alumis
Market Cap: US$3.4b
A clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders.
ALMS
US$26.40
7D
12.8%
1Y
774.2%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$40.2b
A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.
2315
HK$40.50
7D
-1.1%
1Y
78.8%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$97.5b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$418.00
7D
0.5%
1Y
27.8%
Tecan Group
Market Cap: CHF 2.0b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 162.60
7D
7.2%
1Y
0.6%
BioNTech
Market Cap: US$23.1b
Engages in the development and commercialization of immunotherapies in Germany.
BNTX
US$91.22
7D
0.4%
1Y
-14.5%
Gedeon Richter
Market Cap: Ft2.2t
Researches, develops, manufactures, markets, and sells pharmaceutical products.
RICHTER
Ft12,260.00
7D
4.5%
1Y
21.3%
Medpace Holdings
Market Cap: US$15.1b
Provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
MEDP
US$527.07
7D
14.5%
1Y
69.6%
Revolution Medicines
Market Cap: US$38.7b
A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.
RVMD
US$182.08
7D
11.7%
1Y
393.3%
Financière de Tubize
Market Cap: €10.0b
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium.
TUB
€225.40
7D
1.2%
1Y
66.5%